Research News and Research

RSS

New research blames billions in medical costs on obesity

Joint research from Cornell University and Lehigh University finds that nearly 17% of U.S. medical costs can be blamed on obesity.

20 Oct 2010

Candidates continue to clash over health care law

Candidates around the nation are increasingly focusing on what they'll do with the new health law if they're elected as clashes over the overhaul's usefulness and future continue to occur on the campaign trail.

20 Oct 2010

Gilead Sciences third quarter total revenues increase 8% to $1.94 billion

Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.

20 Oct 2010

As state commissioners meet on medical loss ratio, insurers warn of impact

Insurers are warning that a provision in the health law that requires them to spend 80 or 85 percent of premiums they collect on actual medical costs and not administrative expenses could put them out of business.

20 Oct 2010

Long term exposure to air pollution increases risk of severe COPD

Long term exposure to low-level air pollution may increase the risk of severe chronic obstructive pulmonary disease (COPD), according to researcher s in Denmark. While acute exposure of several days to high level air pollution was known to be a risk factor for exacerbation in pre-existing COPD, until now there had been no studies linking long-term air pollution exposure to the development or progression of the disease.

20 Oct 2010

454 Life Sciences enters co-promotional agreement with Fluidigm

454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.

20 Oct 2010

State Roundup: Md.'s heath info exchange; LA to cut retiree health benefits; N.Y.'s mental health building boom

The Washington Post: "A Maryland health information exchange that will allow hospitals, physicians, labs and radiology centers to share patient information within the state went live last week. Three hospitals, three radiology centers, Quest Diagnostics and the Laboratory Corp. of America are already participating in the exchange."

20 Oct 2010

Researchers to study effectiveness of gamma-tocotrienol on prostate cancer cells

Survival rates of the world's most common cancer might soon be increased with a new vitamin E treatment which could significantly reduce tumour regrowth. Queensland University of Technology (QUT) prostate cancer researchers are leading the fight against a disease which kills 3000 Australian men a year.

20 Oct 2010

Ceregene commences enrollment in CERE-120 Phase 2b study for Parkinson's disease

Ceregene, Inc., a biopharmaceutical company, announced today that enrollment has begun in a new double-blind sham surgery-controlled Phase 2b study evaluating CERE-120 in Parkinson's disease patients. CERE-120 is a gene therapy product that delivers the neurotrophic factor neurturin to degenerating or dying dopamine neurons. Data from the first Phase 2 clinical trial of CERE-120 are being published later this year in Lancet Neurology (to appear online October 21, 2010).

20 Oct 2010

Boeing to shift health costs to workers

The Wall Street Journal: Boeing will increase the costs of health insurance for its 90,000 nonunion workers next year in response to rising health costs, spurred, in part, a Boeing official said, by the federal health law. The company plans to "phase in higher employee costs for deductibles, co-payments and co-insurance during 2011.

20 Oct 2010

Anticoagulant Pradaxa receives FDA approval for prevention of stroke in atrial fibrillation patients

The U.S. Food and Drug Administration today approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation).

20 Oct 2010

Autistic children with poor diet face risk of vision loss due to vitamin B12 deficiency

Autistic children with severely limited diets may be at risk for vision loss due to vitamin B12 deficiency, according to new research from The Children's Hospital of Philadelphia. Doctors should consider this deficiency when evaluating and treating children with autism and vision loss, the authors said.

20 Oct 2010

Opinions: Mdgs in Africa; development maintenance; U.S. efforts to eradicate polio; Global Fund commitment

Addressing the Millennium Development Goals (MDGs) in Africa will not only require extra spending, but also better spending, as well as the improvement of social services and priority setting, Kingsley Alu writes in a Leadership column.

20 Oct 2010

Genes and alcoholism link explored: Study

According to the latest research in the U.S., a genetic variation may protect against alcoholism, and this could lead to a novel preventative treatment. The researchers say that a gene variant known as CYP2EI is linked to people's response to alcohol.

19 Oct 2010

Fish oil not as good for pregnant mums as thought: Study

According to a new Australian study, taking fish oil / docosahexaenoic acid (DHA) supplements during pregnancy does not appear to reduce the risk of postpartum depression of mothers or boost the language development and cognitive skills of their children.

19 Oct 2010

Protein hormone inhibits leptin-induced migration of liver cancer cells

A research team from Emory University School of Medicine investigated the role between adiponectin and leptin in obesity-related carcinogenesis. Their findings, published in the November issue of Hepatology, suggest that the protein hormone adiponectin has potential for inhibiting the oncogenic actions of leptin, namely in hepatocellular carcinoma (HCC), and could offer a promising therapy for the disease.

19 Oct 2010

BioMarin announces BMN-111 program for treatment of achondroplasia

BioMarin Pharmaceutical Inc. today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia. BioMarin plans to file an IND in the fourth quarter of 2011 and to initiate a Phase 1 clinical trial by the first quarter of 2012.

19 Oct 2010

Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $1.00 in the second quarter of fiscal 2011.

19 Oct 2010

Scientists probe functional connectivity among neurons in auditory cortex gives rise to map of acoustic space

Just as we visually map a room by spatially identifying the objects in it, we map our aural world based on the frequencies of sounds. The neurons within the brain's "hearing center"-the auditory cortex-are organized into modules that each respond to sounds within a specific frequency band. But how responses actually emanate from this complex network of neurons is still a mystery.

19 Oct 2010

Pharmacy graduate awarded national recognition for pioneering research in genetics

A young pharmacy graduate has been awarded national recognition for her pioneering research in the field of genetics which has the potential to treat diseases such as cancer and Parkinson's.

19 Oct 2010

Research News and Research

New research blames billions in medical costs on obesity

Candidates continue to clash over health care law

Gilead Sciences third quarter total revenues increase 8% to $1.94 billion

As state commissioners meet on medical loss ratio, insurers warn of impact

Long term exposure to air pollution increases risk of severe COPD

454 Life Sciences enters co-promotional agreement with Fluidigm

State Roundup: Md.'s heath info exchange; LA to cut retiree health benefits; N.Y.'s mental health building boom

Researchers to study effectiveness of gamma-tocotrienol on prostate cancer cells

Ceregene commences enrollment in CERE-120 Phase 2b study for Parkinson's disease

Boeing to shift health costs to workers

Anticoagulant Pradaxa receives FDA approval for prevention of stroke in atrial fibrillation patients

Autistic children with poor diet face risk of vision loss due to vitamin B12 deficiency

Opinions: Mdgs in Africa; development maintenance; U.S. efforts to eradicate polio; Global Fund commitment

Genes and alcoholism link explored: Study

Fish oil not as good for pregnant mums as thought: Study

Protein hormone inhibits leptin-induced migration of liver cancer cells

BioMarin announces BMN-111 program for treatment of achondroplasia

Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million

Scientists probe functional connectivity among neurons in auditory cortex gives rise to map of acoustic space

Pharmacy graduate awarded national recognition for pioneering research in genetics

A guide to advancing biotherapeutic research eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News